New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
{{output}}
The introduction of trastuzumab for the treatment of tumors that overexpress ErbB2 (also known as HER2) has contributed significantly to recent improvements in systemic therapy for advanced breast cancer. The advances in systemic therapy have highlighted an in... ...
